venBio Select Advisor »

Ascendis Pharma AS shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4B 5.1M 266.72

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Ordinary Shares (ASND)
Krystal Biotech Common (KRYS)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Revolution Medicines Common (RVMD)
Cytokinetics Common (CYTK)
Celcuity Common (CELC)
Structure Therapeutics Sponsored Ads (GPCR)
Xenon Pharmaceuticals Common (XENE)
Definium Therapeutics Common (DFTX)
Uniqure Nv Common (QURE)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS